Effective Topical Treatments for Psoriasis

First-Line Topical Treatments

The American Academy of Dermatology recommends topical corticosteroids as initial therapy for plaque psoriasis not involving intertriginous areas, with class 1-3 (high to ultra-high potency) for up to 4 weeks 2
Efficacy rates in randomized controlled trials range from 58% to 92% for ultra-high potency corticosteroids 2
The American Academy of Dermatology suggests selecting topical corticosteroids based on disease severity, location, patient age, and vehicle preference 2, 3
The recommended dosing for topical corticosteroids is 1-2 times daily, with a maximum of 50g weekly for class 1 steroids like clobetasol 3

The American Academy of Dermatology recommends long-term use (up to 52 weeks) of vitamin D analogues for mild to moderate psoriasis with strong evidence 1, 4, 5
Available options include calcipotriene/calcipotriol, calcitriol, tacalcitol, and maxacalcitol 1
Vitamin D analogues exert therapeutic effects by inhibiting keratinocyte proliferation and enhancing differentiation 6

The American Academy of Dermatology recommends combination therapy with corticosteroids and vitamin D analogues for enhanced efficacy, with strong evidence (Grade A recommendation) 1, 4
Available fixed combination products include calcipotriene plus betamethasone dipropionate 6
Recommended maintenance regimens include vitamin D analogues twice daily on weekdays with high-potency corticosteroids twice daily on weekends 1, 5

The American Academy of Dermatology recommends topical corticosteroids (classes 1-7) for at least 4 weeks for scalp psoriasis 2
Calcipotriene foam and calcipotriene plus betamethasone dipropionate gel are recommended for 4-12 weeks for scalp psoriasis 1, 5
Lower potency corticosteroids are recommended for facial and intertriginous psoriasis to minimize adverse effects 2
Tacalcitol ointment or calcipotriene with hydrocortisone are effective for 8 weeks for facial and intertriginous psoriasis 1, 6

The American Academy of Dermatology warns of the risk of skin atrophy, striae, and hypothalamic-pituitary-adrenal axis suppression with prolonged use of corticosteroids 2, 3
Tachyphylaxis (decreased effectiveness over time) may occur with corticosteroids 3
The American Academy of Dermatology advises against simultaneous use of salicylic acid with vitamin D analogues, as the acidic pH inactivates calcipotriene 1, 4, 5

For mild-moderate plaque psoriasis, start with a high-potency topical corticosteroid once or twice daily for 2-4 weeks, then add or switch to vitamin D analogue for maintenance (up to 52 weeks) 1, 2, 5
For scalp psoriasis, use corticosteroid solutions/foams or calcipotriene plus betamethasone dipropionate gel 1, 3
For facial/intertriginous areas, use low-potency corticosteroids or calcipotriene with hydrocortisone 1, 6
For maintenance therapy, consider weekend-only corticosteroid with weekday vitamin D analogue application or morning corticosteroid with evening vitamin D analogue 1, 5